Treace Medical Concepts Statistics
Total Valuation
TMCI has a market cap or net worth of $186.69 million. The enterprise value is $204.43 million.
Important Dates
The last earnings date was Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TMCI has 63.72 million shares outstanding. The number of shares has increased by 1.51% in one year.
| Current Share Class | 63.72M |
| Shares Outstanding | 63.72M |
| Shares Change (YoY) | +1.51% |
| Shares Change (QoQ) | +0.81% |
| Owned by Insiders (%) | 25.06% |
| Owned by Institutions (%) | 77.29% |
| Float | 47.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.82 |
| Forward PS | 0.89 |
| PB Ratio | 2.04 |
| P/TBV Ratio | 2.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.37, with a Debt / Equity ratio of 0.79.
| Current Ratio | 3.37 |
| Quick Ratio | 2.22 |
| Debt / Equity | 0.79 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.16 |
Financial Efficiency
Return on equity (ROE) is -51.63% and return on invested capital (ROIC) is -18.08%.
| Return on Equity (ROE) | -51.63% |
| Return on Assets (ROA) | -14.77% |
| Return on Invested Capital (ROIC) | -18.08% |
| Return on Capital Employed (ROCE) | -31.08% |
| Revenue Per Employee | $458,866 |
| Profits Per Employee | -$105,050 |
| Employee Count | 477 |
| Asset Turnover | 1.07 |
| Inventory Turnover | 1.04 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.30% in the last 52 weeks. The beta is 0.69, so TMCI's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | -61.30% |
| 50-Day Moving Average | 5.73 |
| 200-Day Moving Average | 6.73 |
| Relative Strength Index (RSI) | 23.91 |
| Average Volume (20 Days) | 1,119,427 |
Short Selling Information
The latest short interest is 3.48 million, so 5.45% of the outstanding shares have been sold short.
| Short Interest | 3.48M |
| Short Previous Month | 3.54M |
| Short % of Shares Out | 5.45% |
| Short % of Float | 7.28% |
| Short Ratio (days to cover) | 14.32 |
Income Statement
In the last 12 months, TMCI had revenue of $218.88 million and -$50.11 million in losses. Loss per share was -$0.80.
| Revenue | 218.88M |
| Gross Profit | 174.83M |
| Operating Income | -48.38M |
| Pretax Income | -50.11M |
| Net Income | -50.11M |
| EBITDA | -39.33M |
| EBIT | -48.38M |
| Loss Per Share | -$0.80 |
Full Income StatementBalance Sheet
The company has $57.42 million in cash and $70.37 million in debt, giving a net cash position of -$12.96 million or -$0.20 per share.
| Cash & Cash Equivalents | 57.42M |
| Total Debt | 70.37M |
| Net Cash | -12.96M |
| Net Cash Per Share | -$0.20 |
| Equity (Book Value) | 89.19M |
| Book Value Per Share | 1.40 |
| Working Capital | 97.09M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$12.15 million and capital expenditures -$14.19 million, giving a free cash flow of -$26.34 million.
| Operating Cash Flow | -12.15M |
| Capital Expenditures | -14.19M |
| Free Cash Flow | -26.34M |
| FCF Per Share | -$0.41 |
Full Cash Flow StatementMargins
Gross margin is 79.87%, with operating and profit margins of -22.10% and -22.89%.
| Gross Margin | 79.87% |
| Operating Margin | -22.10% |
| Pretax Margin | -22.89% |
| Profit Margin | -22.89% |
| EBITDA Margin | -17.97% |
| EBIT Margin | -22.10% |
| FCF Margin | n/a |
Dividends & Yields
TMCI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.51% |
| Shareholder Yield | -1.51% |
| Earnings Yield | -26.17% |
| FCF Yield | -13.76% |
Analyst Forecast
The average price target for TMCI is $7.07, which is 141.30% higher than the current price. The consensus rating is "Hold".
| Price Target | $7.07 |
| Price Target Difference | 141.30% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TMCI has an Altman Z-Score of 1.69 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.69 |
| Piotroski F-Score | 2 |
